ProfileGDS4718 / 202717_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 83% 75% 87% 81% 84% 86% 90% 76% 83% 80% 81% 80% 86% 92% 88% 83% 86% 87% 83% 81% 78% 81% 84% 83% 77% 89% 83% 87% 78% 87% 84% 91% 79% 80% 94% 93% 82% 80% 83% 89% 82% 91% 84% 87% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.2012783
GSM549102patient 115, normal, homogenized [OPG study]7.2553675
GSM549104patient 119, normal, homogenized [OPG study]8.8515987
GSM549108patient 138, normal, homogenized [OPG study]7.9081381
GSM549119patient 077, normal, homogenized [OPG study]8.2316384
GSM549133patient 032, cancer, homogenized [OPG study]8.6774186
GSM549139patient 042, cancer, homogenized [OPG study]9.1214990
GSM549099patient 107, normal, homogenized [OPG study]7.3817576
GSM549109patient 139, normal, homogenized [OPG study]8.1244283
GSM549110patient 046, normal, homogenized [OPG study]7.8417280
GSM549114patient 063, normal, homogenized [OPG study]8.0645481
GSM549122patient 082, normal, homogenized [OPG study]7.8998280
GSM549134patient 033, cancer, homogenized [OPG study]8.6893786
GSM549136patient 036, cancer, homogenized [OPG study]9.580492
GSM549140patient 044, cancer, homogenized [OPG study]8.9976688
GSM549111patient 047, normal, homogenized [OPG study]8.3032383
GSM549113patient 057, normal, homogenized [OPG study]8.7726486
GSM549132patient 031, cancer, homogenized [OPG study]8.6860387
GSM549137patient 038, cancer, homogenized [OPG study]8.1949983
GSM549142patient 047, cancer, homogenized [OPG study]7.6650981
GSM549100patient 110, normal, homogenized [OPG study]7.5773978
GSM549107patient 135, normal, homogenized [OPG study]7.9848681
GSM549115patient 068, normal, homogenized [OPG study]8.4739284
GSM549116patient 072, normal, homogenized [OPG study]8.2376983
GSM549120patient 078, normal, homogenized [OPG study]7.5106777
GSM549131patient 030, cancer, homogenized [OPG study]9.1471389
GSM549118patient 074, normal, homogenized [OPG study]8.2112283
GSM549129patient 027, cancer, homogenized [OPG study]8.6646387
GSM549123patient 088, normal, homogenized [OPG study]7.6929178
GSM549124patient 006, cancer, homogenized [OPG study]8.5747387
GSM549126patient 015, cancer, homogenized [OPG study]8.2994184
GSM549128patient 025, cancer, homogenized [OPG study]9.2844391
GSM549103patient 117, normal, homogenized [OPG study]7.615279
GSM549117patient 073, normal, homogenized [OPG study]7.8419780
GSM549138patient 041, cancer, homogenized [OPG study]9.8597194
GSM549141patient 045, cancer, homogenized [OPG study]9.8903793
GSM549130patient 028, cancer, homogenized [OPG study]8.0885182
GSM549101patient 111, normal, homogenized [OPG study]7.8103380
GSM549105patient 128, normal, homogenized [OPG study]8.2301483
GSM549106patient 134, normal, homogenized [OPG study]9.1096189
GSM549112patient 048, normal, homogenized [OPG study]8.1563982
GSM549125patient 011, cancer, homogenized [OPG study]9.2202191
GSM549127patient 024, cancer, homogenized [OPG study]8.316784
GSM549135patient 035, cancer, homogenized [OPG study]8.8568687